Skip to main navigation Skip to search Skip to main content

Once‐Daily Naftifine Cream 1% in the Treatment of Tinea Cruris and Tinea Corporis

  • Robert E. Jordon
  • , Ronald P. Rapini
  • , Ira H. Rex
  • , H. Irving Katz
  • , Janet G. Hickman
  • , James W. Bard
  • , Roland S. Medansky
  • , Deborah A. Lew‐Kaya
  • , John Sefton
  • , Ronald E. DeGryse
  • , Frank P. Killey

Research output: Contribution to journalArticlepeer-review

Abstract

Seventy patients with tinea cruris or tinea corporis were treated with naftifine cream 1% or vehicle once daily (or 4 weeks in this double‐blind, randomized study. After two weeks, the patients using naftifine had a significantly higher mycologic cure rate than the vehicle‐treated patients (79% vs. 31 %, p < 0.001), and they showed significantly better resolution of signs and symptoms. Statistically significant differences favoring naftifine over its vehicle were found throughout the treatment period and 2 weeks posttreatment.

Original languageEnglish (US)
Pages (from-to)441-442
Number of pages2
JournalInternational Journal of Dermatology
Volume29
Issue number6
DOIs
StatePublished - Jul 1990

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Once‐Daily Naftifine Cream 1% in the Treatment of Tinea Cruris and Tinea Corporis'. Together they form a unique fingerprint.

Cite this